Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexketoprofen Trometamol Injection for Postoperative Moderate to Severe Pain
CTR20250538Phase 3Terminated
- Sponsor
- Beijing Baiao Pharmaceuticals
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexketoprofen in postoperative pain, sponsored by Beijing Baiao Pharmaceuticals. Started Feb 2025; status: terminated.
02
Drugs
dexketoprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20250538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250538.